Next-generation Sequencing Informatics Market by Product, Application and End User : Global Opportunity Analysis and Industry Forecast, 2021–2030

Next-generation Sequencing Informatics Market by Product, Application and End User : Global Opportunity Analysis and Industry Forecast, 2021–2030

  • December 2021 •
  • 257 pages •
  • Report ID: 6236863 •
  • Format: PDF
Next-generation Sequencing Informatics Market by Product (Data Analysis & Management Tools, NGS Informatics Services, and Primary and Secondary Data Analysis Tools), Application (Drug Discovery, Diagnostics, Biomarker Discovery, Precision Medicine, and Agriculture & Animal Research) and End User (Hospitals and Clinics, Academic and Research Centers, Pharmaceutical Companies, and Other End Users): Global Opportunity Analysis and Industry Forecast, 2021–2030

The global next generation sequencing informatics market accounted for $933.18 million in 2020, and is projected to reach $3,186.69 million by 2030, registering a CAGR of 13.30% from 2021 to 2030.
The next-generation DNA sequencing (NGS) technology has made genome and RNA sequencing cost-effective, and can be frequently used as a tool for a wide variety of research applications. The various applications employed under NGS informatics is metagenomics, gene expression, epigenetics and many others. Next generation sequencing informatics uses the bioinformatics methods to support DNA sequencing for researchers and organizations, making DNA sequencing easier.
The factors that drive the growth of the next generation sequencing informatics market include rising awareness and increasing use of the technology, ever-increasing R&D activities, and technological advancements. It aims to understand the biochemistry and the response of ocean to environmental pollution, nutrient stress, and climatic change by conducting the genomic mapping of microorganism. In addition, rise in awareness pertaining to next generation sequencing technologies and rise in investment in research, development, and innovation, supplement the market growth.
Having said that, lack in accuracy, and standardization concerns observed in the process are causing hindrance in the next generation sequencing informatics market. Along with this, stringent regulations and policies by the government can impede the market growth.
However, rising prevalence across the globe of cancer disease and the increasing popularity of personalized medicines are creating lucrative opportunities for the next generation sequencing informatics market.
The next generation sequencing informatics market is segmented on the basis of product, application, end user, and region. By product, the market is classified into data analysis and management tools, NGS informatics services, and primary and secondary data analysis tools. The data analysis and management tools is sub-segmented into Laboratory Information Management System (LIMS), and Data Interpretation and Reporting Tools. The application segment is further classified based on drug discovery, diagnostics, biomarker discovery, precision medicine and agriculture & animal research. The end user segment is segmented into hospitals and clinics, academic and research centers, pharmaceutical companies and other end users.
Region wise, this market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the next generation sequencing informatics market in 2020, and is expected to retain its dominance throughout the forecast period. This is primarily attributed to the presence of high per capita healthcare expenditure, coupled with high patient awareness levels and high prevalence of target diseases. On the other hand, Asia-Pacific region is projected to grow at a fastest CAGR during the forecast period, due to increasing population, rising rate of diseases, and various government initiatives for genomic research for understanding the complex biological process and genetic mutation present in life threatening diseases.
The key companies profiled in the report include Illumina, Inc., Thermo Fischer Scientific, Inc., Agilent Technologies Inc., F. Hoffmann-La Roche AG, Qiagen N.V., DNANexus Inc., Intrexon Bioinformatics Germany GmbH, Partek Incorporated, Fabric Genomics Inc., and Sapio Sciences.

• The report provides in-depth analysis of the global next generation sequencing informatics market size along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
• A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global next generation sequencing informatics market growth.


By Product
• Data Analysis and Management Tools
o Laboratory Information Management System (LIMS)
o Data Interpretation and Reporting Tools
• NGS informatics services
• Primary & Secondary Data Analysis Tools

By Application
• Drug Discovery
• Diagnostics
• Biomarker Discovery
• Precision Medicine
• Agriculture and Animal Research

By End User
• Hospitals and Clinics
• Academic and Research Centers
• Pharmaceutical Companies
• Other end users

By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o Australia
o India
o South Korea
o Taiwan
o Rest of Asia-Pacific
o Brazil
o Saudi Arabia
o South Africa
o Turkey
o Rest of LAMEA

List of key players profiled in the report:
• BIllumina, Inc.
• Thermo Fischer Scientific, Inc.
• Agilent Technologies Inc.
• F. Hoffmann-La Roche AG
• Qiagen N.V.
• DNANexus Inc.
• Intrexon Bioinformatics Germany GmbH
• Partek Incorporated
• Fabric Genomics Inc.
• Sapio Sciences